The Role and Mechanisms of UBQLN2-mediated Phase Transitions in the Assembly and Disassembly of Biomolecular Condensates
UBQLN2介导的相变在生物分子凝聚体组装和分解中的作用和机制
基本信息
- 批准号:10582154
- 负责人:
- 金额:$ 4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAutophagocytosisBindingBiologicalBiophysical ProcessCell Culture TechniquesCell physiologyCellsCellular Stress ResponseCharacteristicsClientCytoplasmic InclusionDiseaseFoundationsGenetic TranscriptionIn VitroLibrariesLinkLiquid substanceMaintenanceMammalian CellMediatingModelingMolecularMonitorMorphologyMutationNaturePathway interactionsPhasePhase TransitionPhysiologicalPolyubiquitinProcessPropertyProteinsQuality ControlRegulationRoleSignal TransductionSolidStressSystemTimeUbiquitindesignin vivomembermutantprotein functionproteostasisreceptorreconstitutionrecruitresponsespatiotemporalstress granule
项目摘要
PROJECT SUMMARY/ABSTRACT:
Biomolecular condensates are dynamic, membraneless compartments that spatiotemporally regulate a
myriad of cellular functions from gene transcription to cellular stress response. Liquid-liquid phase
separation (LLPS) is increasingly appreciated as the biophysical mechanism for how these condensates
assemble. Key to proper condensate function is the maintenance of their dynamics and
assembly/disassembly processes, but little is known about these mechanisms. Hints are provided from
disease states whereby condensates may undergo liquid-to-solid transitions into cytoplasmic inclusions
that contain protein quality control components and are characteristic of proteinopathies such as
amyotrophic lateral sclerosis. We have identified UBQLN2, a member of ubiquitin-mediated protein
quality control systems, as a contributor to condensate function. We recently showed that UBQLN2 forms
condensates in vitro, and is recruited to stress granules, cytoplasmic condensates that form in response
to stress. The multitude of UBQLN2 functions are driven through interactions with proteasomal subunits,
polyubiquitin chains, and client proteins. Ubiquitin and polyubiquitin, biological signals for the
maintenance of protein homeostasis through degradation and autophagy, drive disassembly of UBQLN2
condensates in vitro. These observations have broad implications for how phase separation mechanisms
regulate the function of protein quality control systems. In this project, we aim to identify the molecular
and cellular mechanisms that drive how UBQLN2 condensates assemble and disassemble. Aim 1
determines how domain-domain interactions promote or inhibit phase separation of UBQLN2 via
construction of phase diagrams for constructs from a combination of UBQLN2 domain deletion and
disease-linked mutations. These domain deletions will be used to mimic the different “states” of UBQLN2
when specific domains are engaged with binding partners and unable to contribute to LLPS. We will use
UBQLN2 disease-linked mutations as a nature-provided library to elucidate how intra- and intermolecular
UBQLN2 interactions promote or inhibit condensate assembly and alter condensate morphology and
material properties both in vitro and in mammalian cell culture models. Aim 2 quantifies how UBQLN2
condensates are affected by UBQLN2 engagement with protein quality control components, including
proteasomal receptors, client proteins, and different types of polyubiquitin chains. We monitor these
effects in vitro and with designed mutants in vivo. Importantly, we develop a reconstituted UBQLN2
condensate model to quantify the parameters of how polyubiquitin and polyubiquitinated substrates
engage with UBQLN2 to disassemble condensates. These studies will lay the foundation for determining
the physiological roles of phase separation as it pertains to protein homeostasis through ubiquitin-
mediated pathways.
项目总结/摘要:
生物分子凝聚物是动态的,无膜的隔间,时空调节生物分子的凝聚物。
从基因转录到细胞应激反应的无数细胞功能。液-液相
分离(LLPS)越来越多地被认为是这些冷凝物
集合。正确冷凝功能的关键是保持其动力学,
组装/拆卸过程,但对这些机制知之甚少。提示来自
疾病状态,其中冷凝物可能经历液体到固体的转变成为细胞质内含物
其含有蛋白质质量控制组分,并且是蛋白质病的特征,
肌萎缩侧索硬化症我们已经鉴定了UBQLN 2,它是泛素介导的蛋白质的一个成员,
质量控制系统,作为冷凝功能的贡献者。我们最近发现UBQLN 2形成于
在体外凝聚,并被募集到应激颗粒,细胞质凝聚物,
压力UBQLN 2的多种功能是通过与蛋白酶体亚基的相互作用来驱动的,
多聚泛素链和客户蛋白。泛蛋白和聚泛蛋白,
通过降解和自噬维持蛋白质稳态,驱动UBQLN 2的分解
体外凝聚。这些观察结果对于相分离机制如何
调节蛋白质质量控制系统的功能。在这个项目中,我们的目标是确定分子
以及驱动UBQLN 2凝聚体组装和分解的细胞机制。要求1
确定结构域-结构域相互作用如何促进或抑制UBQLN 2的相分离,
构建来自UBQLN 2结构域缺失和UBQLN 3结构域缺失的组合的构建体的相图。
疾病相关突变这些结构域缺失将用于模拟UBQLN 2的不同“状态
当特定的结构域与结合伴侣结合并且不能促进LLPS时。我们将使用
UBQLN 2疾病相关突变作为自然提供的文库,以阐明分子内和分子间
UBQLN 2相互作用促进或抑制冷凝物组装并改变冷凝物形态,
在体外和哺乳动物细胞培养模型中的材料特性。目标2量化UBQLN 2
缩合物受到UBQLN 2与蛋白质质量控制组分的接合的影响,包括
蛋白酶体受体、客户蛋白和不同类型的聚泛素链。我们监测这些
体外和体内设计的突变体的效果。重要的是,我们开发了重组的UBQLN 2
冷凝物模型,以量化多聚泛素和多聚泛素化底物
与UBQLN 2接合以分解冷凝物。这些研究将为确定
相分离的生理作用,因为它涉及蛋白质稳态通过泛素-
介导的路径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carlos Antonio Castaneda其他文献
Carlos Antonio Castaneda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carlos Antonio Castaneda', 18)}}的其他基金
The Role and Mechanisms of UBQLN2-mediated Phase Transitions in the Assembly and Disassembly of Biomolecular Condensates
UBQLN2介导的相变在生物分子凝聚体组装和分解中的作用和机制
- 批准号:
10334494 - 财政年份:2020
- 资助金额:
$ 4万 - 项目类别:
The Role and Mechanisms of UBQLN2-mediated Phase Transitions in the Assembly and Disassembly of Biomolecular Condensates
UBQLN2介导的相变在生物分子凝聚体组装和分解中的作用和机制
- 批准号:
10551259 - 财政年份:2020
- 资助金额:
$ 4万 - 项目类别:
The Role and Mechanisms of UBQLN2-mediated Phase Transitions in the Assembly and Disassembly of Biomolecular Condensates
UBQLN2介导的相变在生物分子凝聚体组装和分解中的作用和机制
- 批准号:
10117270 - 财政年份:2020
- 资助金额:
$ 4万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 4万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 4万 - 项目类别:
Fellowship